JP6842127B2 - 細胞毒性剤と細胞結合受容体との共役体 - Google Patents

細胞毒性剤と細胞結合受容体との共役体 Download PDF

Info

Publication number
JP6842127B2
JP6842127B2 JP2019095746A JP2019095746A JP6842127B2 JP 6842127 B2 JP6842127 B2 JP 6842127B2 JP 2019095746 A JP2019095746 A JP 2019095746A JP 2019095746 A JP2019095746 A JP 2019095746A JP 6842127 B2 JP6842127 B2 JP 6842127B2
Authority
JP
Japan
Prior art keywords
antibody
alkyl
heteroalkyl
cycloalkyl
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019095746A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019167359A (ja
JP2019167359A5 (enrdf_load_stackoverflow
Inventor
ヨンシン ジャオ、アール
ヨンシン ジャオ、アール
ジャン、ユエ
マ、ヨウラン
Original Assignee
ハンヂョウ ディーエイシー バイオテック カンパニー リミテッド
ハンヂョウ ディーエイシー バイオテック カンパニー リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ハンヂョウ ディーエイシー バイオテック カンパニー リミテッド, ハンヂョウ ディーエイシー バイオテック カンパニー リミテッド filed Critical ハンヂョウ ディーエイシー バイオテック カンパニー リミテッド
Priority to JP2019095746A priority Critical patent/JP6842127B2/ja
Publication of JP2019167359A publication Critical patent/JP2019167359A/ja
Publication of JP2019167359A5 publication Critical patent/JP2019167359A5/ja
Application granted granted Critical
Publication of JP6842127B2 publication Critical patent/JP6842127B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
JP2019095746A 2019-05-22 2019-05-22 細胞毒性剤と細胞結合受容体との共役体 Active JP6842127B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019095746A JP6842127B2 (ja) 2019-05-22 2019-05-22 細胞毒性剤と細胞結合受容体との共役体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2019095746A JP6842127B2 (ja) 2019-05-22 2019-05-22 細胞毒性剤と細胞結合受容体との共役体

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017057224A Division JP6585650B2 (ja) 2017-03-23 2017-03-23 細胞毒性剤と細胞結合受容体との共役体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021016477A Division JP7044419B2 (ja) 2021-02-04 2021-02-04 細胞毒性剤と細胞結合受容体との共役体

Publications (3)

Publication Number Publication Date
JP2019167359A JP2019167359A (ja) 2019-10-03
JP2019167359A5 JP2019167359A5 (enrdf_load_stackoverflow) 2020-02-06
JP6842127B2 true JP6842127B2 (ja) 2021-03-17

Family

ID=68106227

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019095746A Active JP6842127B2 (ja) 2019-05-22 2019-05-22 細胞毒性剤と細胞結合受容体との共役体

Country Status (1)

Country Link
JP (1) JP6842127B2 (enrdf_load_stackoverflow)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101678124A (zh) * 2007-03-14 2010-03-24 恩多塞特公司 结合配体连接的微管溶素递药缀合物
US8394922B2 (en) * 2009-08-03 2013-03-12 Medarex, Inc. Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof

Also Published As

Publication number Publication date
JP2019167359A (ja) 2019-10-03

Similar Documents

Publication Publication Date Title
JP6117921B2 (ja) 細胞毒性剤と細胞結合受容体との共役体
JP6817288B2 (ja) 新規な連結体及び生体分子と薬物との特異的共役におけるその使用
JP6759326B2 (ja) 細胞結合分子の共役のための架橋連結体
JP6700321B2 (ja) 細胞結合分子の特異的共役体
CN105641707B (zh) 细胞毒素分子同细胞结合受体分子的共轭体
CN108026123A (zh) 用于偶联的亲水链接体
JP7149610B2 (ja) 細胞結合分子の特異的共役体
JP2021006531A (ja) 細胞結合分子の共役のための架橋連結体
JP6585650B2 (ja) 細胞毒性剤と細胞結合受容体との共役体
JP2023159139A (ja) 新規な連結体及び生体分子と薬物との特異的共役におけるその使用
JP7044419B2 (ja) 細胞毒性剤と細胞結合受容体との共役体
JP6842127B2 (ja) 細胞毒性剤と細胞結合受容体との共役体
HK1258097A1 (en) Conjugates of cell binding molecules with cytotoxic agents
NZ719369A (en) Conjugates of cell binding molecules with cytotoxic agents
NZ719369B2 (en) Conjugates of Cell Binding Molecules with Cytotoxic Agents
HK1210059B (en) Conjugates of cell binding molecules with cytotoxic agents

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190621

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191219

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200407

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200707

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200716

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210105

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210204

R150 Certificate of patent or registration of utility model

Ref document number: 6842127

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250